Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,381–1,400 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass II

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01

by McKesson

Reason
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
Recall initiated
January 17, 2025
Reported by FDA
February 5, 2025
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason
CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit
Recall initiated
January 13, 2025
Reported by FDA
February 5, 2025
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass I

Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.

by Astellas Pharma US Inc.

Reason
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Recall initiated
December 23, 2024
Reported by FDA
February 5, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.

by Astellas Pharma US Inc.

Reason
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Recall initiated
December 23, 2024
Reported by FDA
February 5, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

BADGER 50, ADVENTURE SPORT MINERAL SUNSCREEN WITH CLEAR ZINC, (uncoated 25% zinc oxide), 2.4 oz., Tin, W.S. Badger Company, Inc, 768 Route 10, Gilsum NH, 03448 UPC 6 34084 47150 2

by The W.S. Badger Company, Inc.

Reason
Labeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.
Recall initiated
January 17, 2025
Reported by FDA
February 5, 2025
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Completed Historical recordClass III

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

by Appco Pharma LLC

Reason
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Recall initiated
January 16, 2025
Reported by FDA
January 29, 2025
Distribution
Nationwide USA.

View recall →

Drug Recall Ongoing Historical recordClass I

FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7

by SHOPPERS- PLAZA

Reason
Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
Recall initiated
December 16, 2024
Reported by FDA
January 29, 2025
Distribution
Nationwide via internet sales

View recall →

Drug Recall Ongoing Historical recordClass II

First Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, Net Wt. 396.8 g (14 OZ), DISTR. BY: First Aid Beauty LTD, Newton, MA, 02458, UPC 8 15517 02955 6

by First Aid Beauty Ltd

Reason
CGMP Deviations; product intended for quarantine was inadvertently distributed
Recall initiated
December 23, 2024
Reported by FDA
January 29, 2025
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Kissable Diabetics Foot Cream, NET WT 4 oz (113 g) per tube, Manufactured By: Brands International Corp., Newmarket, ON, L3X 2S2. UPC 6 72008 80925 3

by Brands International Corporation

Reason
CGMP Deviations: lack of adequate release testing.
Recall initiated
November 13, 2024
Reported by FDA
January 29, 2025
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

by Viatris Inc

Reason
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Recall initiated
December 23, 2024
Reported by FDA
January 22, 2025
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

by Viatris Inc

Reason
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Recall initiated
December 23, 2024
Reported by FDA
January 22, 2025
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

by Amerisource Health Services LLC

Reason
Failed Dissolution Specifications:
Recall initiated
December 17, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-11

by Amerisource Health Services LLC

Reason
Presence of Foreign Tablets/Capsules
Recall initiated
January 7, 2025
Reported by FDA
January 22, 2025
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass I

Systane Lubricant Eye Drops, Ultra PF, Sterile, 25 Vials (0.7mL Each), Manufactured for: Alcon Laboratories, Inc. Forth Worth, TX 76134

by Alcon Research LLC

Reason
Non-Sterility
Recall initiated
December 18, 2024
Reported by FDA
January 22, 2025
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass III

Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02.

by Akron Pharma, Inc.

Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Recall initiated
December 12, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass III

Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.

by Akron Pharma, Inc.

Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Recall initiated
December 12, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass III

Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8028-1.

by Akron Pharma, Inc.

Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Recall initiated
December 12, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass III

Acetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., 373 US RT 46 W Building E, Suite 117, Fairfield, NJ 07034, NDC 71399-8022-02

by Akron Pharma, Inc.

Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Recall initiated
December 12, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass III

Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.

by Akron Pharma, Inc.

Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Recall initiated
December 12, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass III

Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .

by Akron Pharma, Inc.

Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Recall initiated
December 12, 2024
Reported by FDA
January 22, 2025
Distribution
Nationwide in the US

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.